首页> 外文期刊>Journal of Pharmaceutical and Biomedical Analysis: An International Journal on All Drug-Related Topics in Pharmaceutical, Biomedical and Clinical Analysis >Evaluation of analytical tools and multivariate methods for quantification of co-former crystals in ibuprofen-nicotinamide co-crystals
【24h】

Evaluation of analytical tools and multivariate methods for quantification of co-former crystals in ibuprofen-nicotinamide co-crystals

机译:评价布洛芬-烟酰胺共晶体中共晶的分析工具和多元方法

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Co-crystals are multicomponent substances designed by the addition of two or more different molecules in a same crystallographic pattern, in which it differs from the crystallographic motif of its co-formers. The addition of highly soluble molecules, like nicotinamide, in the crystallographic pattern of ibuprofen enhances its solubility more than 7.5 times, improving the properties of this widely used drug. Several analytical solid state techniques are used to characterize the ibuprofen-nicotinamide co-crystal, being the most used: mid-infrared (ATR-FTIR), differential scanning calorimetry (DSC), X-ray diffraction (XRPD) and Raman spectroscopy. These analytical solid state techniques were evaluated to quantify a mixture of ibuprofen-nicotinamide co-crystal and its co-formers in order to develop a calibration model to evaluate the co-crystal purity after its synthesis. Raman spectroscopy showed better result than all other techniques with a combination of multivariate calibration tools, presenting lower values of calibration and prediction errors. The partial least squares regression model gave a mean error lower than 5% for all components presented in the mixture. DSC and mid-infrared spectroscopy proved to be insufficient for quantification of the ternary mixture. XRPD presented good results for quantification of the co-formers, ibuprofen and nicotinamide, but fair results for the co-crystal. This is the first report of quantification of ibuprofen-nicotinamide co-crystal, among its co-formers. The quantification is of great importance to determine the yield of the co-crystallization reactions and the purity of the product obtained.
机译:共晶体是通过在相同的晶体学模式中添加两个或更多个不同的分子而设计的多组分物质,其中,它不同于其共形成者的晶体学图案。在布洛芬的结晶图中添加高度可溶的分子(如烟酰胺)可使其溶解度提高7.5倍以上,从而改善了这种广泛使用的药物的性能。最常用的几种分析固态技术用于表征布洛芬-烟酰胺共晶体:中红外(ATR-FTIR),差示扫描量热法(DSC),X射线衍射(XRPD)和拉曼光谱。对这些分析性固态技术进行了评估,以量化布洛芬-烟酰胺共晶体和其共形成剂的混合物,以便开发校准模型以评估其合成后的共晶体纯度。拉曼光谱结合多元校正工具显示出比所有其他技术更好的结果,校正和预测误差值更低。偏最小二乘回归模型给出的混合物中所有组分的平均误差均低于5%。 DSC和中红外光谱证明不足以量化三元混合物。 XRPD定量定量共形成物布洛芬和烟酰胺表现出良好的结果,但共晶的测定结果却不错。这是定量测定布洛芬-烟酰胺共结晶的首份报告。定量对于确定共结晶反应的收率和所得产物的纯度非常重要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号